Final answer:
PET scans are medical imaging tools that show the function of bodily tissues by using radioactive glucose to detect metabolic activity, which is particularly useful for identifying cancerous cells due to their heightened glucose consumption. It uses gamma radiation detected by a scanner to create images that help diagnose various conditions, despite it now being less commonly used than fMRI.
Step-by-step explanation:
Understanding Positron Emission Tomography (PET) Scans
Positron emission tomography, commonly known as PET scanning, is a diagnostic imaging tool that captures the physiological processes occurring within the body, particularly the brain.
It generates a three-dimensional image of the target area's functional aspects by using a radiotracer, typically a form of radioactive glucose such as fludeoxyglucose (FDG) tagged with a positron emitter like F-18. The FDG is metabolized by the body's tissues, and cancer cells, which have higher metabolic rates, consume glucose more vigorously, thus revealing themselves as bright areas referred to as 'hot spots' during the PET scan imaging process. FDG-PET scans are beneficial for detecting various conditions, including heart disease, Alzheimer's disease, epilepsy, and cancer, due to their ability to show the biological activity and quantify metabolic processes.
The mechanism behind a PET scan involves the radioactive isotope attached to glucose decaying and emitting positrons, which then react with electrons resulting in gamma radiation bursts that the scanner detects. This produces the intricate images that show the functionality of tissues within the brain or other body parts. Although PET scans involve radiation exposure and provide less temporal precision compared to fMRI, they remain an invaluable tool due to their unique functional imaging capabilities, often being combined with computed tomography (CT) for enhanced detail.